Cargando…

Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease

BACKGROUND AND AIMS: Whether non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident chronic kidney disease (CKD) independent of established cardio-renal risk factors remains controversial. We aimed to provide a quantitative estimate of the association and strength...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiaoyan, Sun, Lichang, Liu, Xiong, Zhu, Hailan, Zhang, Yang, Zheng, Sulin, Huang, Yuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237225/
https://www.ncbi.nlm.nih.gov/pubmed/34249302
http://dx.doi.org/10.1177/20406223211024361
_version_ 1783714687975686144
author Cai, Xiaoyan
Sun, Lichang
Liu, Xiong
Zhu, Hailan
Zhang, Yang
Zheng, Sulin
Huang, Yuli
author_facet Cai, Xiaoyan
Sun, Lichang
Liu, Xiong
Zhu, Hailan
Zhang, Yang
Zheng, Sulin
Huang, Yuli
author_sort Cai, Xiaoyan
collection PubMed
description BACKGROUND AND AIMS: Whether non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident chronic kidney disease (CKD) independent of established cardio-renal risk factors remains controversial. We aimed to provide a quantitative estimate of the association and strength between NAFLD and risk of CKD after adjustment for multiple cardio-renal risk factors. METHODS: We searched electronic databases (PubMed, Embase, and Google Scholar) for studies published from database inception until 30 November 2020. Analysis included cohort studies that reported multivariable-adjusted risk ratios [including odds ratios, relative risks (RRs), or hazard ratios] and 95% confidence intervals (CIs) for CKD of NAFLD compared with individuals without NAFLD. RESULTS: A total of 11 cohort studies were included comprising 1,198,242 participants (46.3% women) for analysis. The median follow-up duration was 3.7 years, with 31,922 cases of incident CKD. Compared with individuals without NAFLD, unadjusted models showed that NAFLD was associated with a higher risk of CKD (RR 1.54, 95% CI 1.38–1.71). After adjusting for multiple cardio-renal risk factors, the CKD risk was still significantly increased in patients with NAFLD (RR 1.39, 95% CI 1.27–1.52). Compared with individuals without NAFLD, the adjusted absolute risk increase in NAFLD for CKD was 5.1 (95% CI 3.5–6.8) per 1000 person-years. CONCLUSION: NAFLD is associated with an increased risk of incident CKD independent of established cardio-renal risk factors.
format Online
Article
Text
id pubmed-8237225
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82372252021-07-08 Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease Cai, Xiaoyan Sun, Lichang Liu, Xiong Zhu, Hailan Zhang, Yang Zheng, Sulin Huang, Yuli Ther Adv Chronic Dis Chronic Kidney Disease BACKGROUND AND AIMS: Whether non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident chronic kidney disease (CKD) independent of established cardio-renal risk factors remains controversial. We aimed to provide a quantitative estimate of the association and strength between NAFLD and risk of CKD after adjustment for multiple cardio-renal risk factors. METHODS: We searched electronic databases (PubMed, Embase, and Google Scholar) for studies published from database inception until 30 November 2020. Analysis included cohort studies that reported multivariable-adjusted risk ratios [including odds ratios, relative risks (RRs), or hazard ratios] and 95% confidence intervals (CIs) for CKD of NAFLD compared with individuals without NAFLD. RESULTS: A total of 11 cohort studies were included comprising 1,198,242 participants (46.3% women) for analysis. The median follow-up duration was 3.7 years, with 31,922 cases of incident CKD. Compared with individuals without NAFLD, unadjusted models showed that NAFLD was associated with a higher risk of CKD (RR 1.54, 95% CI 1.38–1.71). After adjusting for multiple cardio-renal risk factors, the CKD risk was still significantly increased in patients with NAFLD (RR 1.39, 95% CI 1.27–1.52). Compared with individuals without NAFLD, the adjusted absolute risk increase in NAFLD for CKD was 5.1 (95% CI 3.5–6.8) per 1000 person-years. CONCLUSION: NAFLD is associated with an increased risk of incident CKD independent of established cardio-renal risk factors. SAGE Publications 2021-06-23 /pmc/articles/PMC8237225/ /pubmed/34249302 http://dx.doi.org/10.1177/20406223211024361 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Chronic Kidney Disease
Cai, Xiaoyan
Sun, Lichang
Liu, Xiong
Zhu, Hailan
Zhang, Yang
Zheng, Sulin
Huang, Yuli
Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
title Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
title_full Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
title_fullStr Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
title_full_unstemmed Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
title_short Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
title_sort non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
topic Chronic Kidney Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237225/
https://www.ncbi.nlm.nih.gov/pubmed/34249302
http://dx.doi.org/10.1177/20406223211024361
work_keys_str_mv AT caixiaoyan nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease
AT sunlichang nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease
AT liuxiong nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease
AT zhuhailan nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease
AT zhangyang nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease
AT zhengsulin nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease
AT huangyuli nonalcoholicfattyliverdiseaseisassociatedwithincreasedriskofchronickidneydisease